External control arms, as an integral part of clinical development, present many potential opportunities for sponsors and ...
In this video interview, Vera Pomerantseva, director of product management, RBQM, eClinical Solutions, highlights FDA’s ...
Following initial positive results shared by Teva and Sanofi in December 2024, new data shows duvakitug (TEV’574/SAR447189) ...
In this video interview, Pomerantseva, director of product management, RBQM, eClinical Solutions, discusses the new guidance and its level of detail on the different types of protocol deviations.
In an interview with Applied Clinical Trials Associate Editor Don Tracy, Shakthi Kumar, chief strategy & business officer, ...
In this video interview, Dipanwita Das, CEO & co-founder, Sorcero; Sujay Jadhav, CEO, Verana Health; and Kimberly Tableman, ...
Symbravo Outperforms Oral CGRP Inhibitors in Phase III Trial, With Faster, Sustained Migraine Relief
Data from the Phase III EMERGE trial show treatment with Symbravo provided more rapid and sustained migraine relief with ...
In this session, experts from Merck KGaA, Darmstadt, Germany reveal how conversational analytics powered by knowledge graphs and natural language interfaces have transformed clinical trial data ...
Tremfya could become the first IL-23 inhibitor with fully subcutaneous induction and maintenance options in the treatment of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback